Event dates estimated.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed and a similar complaint query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.The reported patient effects of claudication and thrombosis are listed in the supera instructions for use (ifu) as known potential patient effects of peripheral percutaneous intervention.A definitive cause for the reported claudication and thrombosis, and the relationship to the product, if any, cannot be determined.A definitive cause for the reported stent fractures could not be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The udi is unknown because the part and lot #s were not provided.Article attachment: title: early supera stent fracture in the femoropopliteal artery.
|
It was reported through a research article identifying a patient that presented with claudication.After pre-dilatation, an unspecified 5x80mm supera self-expanding stent was implanted in the right popliteal artery.12 days later, the patient returned with claudication, thrombus, and stent fractures, which were treated with several balloons.3 days after that, the patient had claudication again, so the patient was sent to bypass surgery and is doing well.No additional information was provided.Details are listed in the attached article, titled "early supera stent fracture in the femoropopliteal artery.".
|